Carregant...
Aspects of prophylactic treatment of hemophilia
Retrospective and prospective studies unambiguously show that prophylactic treatment of severe hemophilia A or B should be started as primary prophylaxis at 1–2 years’ of age and ideally before the first joint bleed. The dose and dose frequency should be individually tailored depending on the goal o...
Guardat en:
| Publicat a: | Thromb J |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056524/ https://ncbi.nlm.nih.gov/pubmed/27766056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-016-0103-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|